logo
Plus   Neg
Share
Email

AstraZeneca To Sell Rights To Seroquel, Seroquel XR In The US, Canada

AstraZeneca (AZN.L) has agreed to sell the commercial rights to Seroquel and Seroquel XR, used to treat schizophrenia and bipolar disorder, in the US and Canada to Cheplapharm Arzneimittel GmbH. Cheplapharm will make an upfront payment of $35 million to AstraZeneca and may also make future sales-contingent payments of up to $6 million.

Ruud Dobber, Executive Vice President, BioPharmaceuticals Business Unit, said: "This divestment supports our strategy of reducing the number of mature medicines to enable reinvestment in our main therapy areas. Cheplapharm recently agreed to acquire the commercial rights to Seroquel and Seroquel XR in most European markets and Russia from AstraZeneca."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Luxury electric car maker Tesla Inc. (TSLA) announced Thursday that it delivered about 90,650 vehicles in the second quarter of 2020, while producing more than 82,000 vehicles. The deliveries include 80,050 Model 3 sedans and Model Y cross-over SUVs as well as 10,600 Model S and X vehicles. The... Boy Scouts of America recalled about 78,000 units of Cub Scout outdoor activity pins for violating the federal lead content ban, a statement by the U.S. Consumer Product Safety Commission (CPSC) showed. The company said the activity pin's face and shaft contain levels of lead that exceed the federal lead content ban. Lead is toxic if ingested by young children and can cause adverse health issues. McDonald's Corp. is delaying the reopening of all dine-in services in its U.S. restaurants by 21 days due to the increase in coronavirus cases across the country, reports said citing an internal letter. The burger chain said, "Our resiliency will be tested again. COVID-19 cases are on the rise."
Follow RTT